These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9004378)

  • 1. Robustness considerations in Bayesian analysis.
    Gustafson P
    Stat Methods Med Res; 1996 Dec; 5(4):357-73. PubMed ID: 9004378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of direct and indirect evidence in mixed treatment comparisons.
    Lu G; Ades AE
    Stat Med; 2004 Oct; 23(20):3105-24. PubMed ID: 15449338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian inference for agreement measures.
    Vidal I; de Castro M
    J Biopharm Stat; 2017; 27(5):809-823. PubMed ID: 27562901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal Bayesian inference dipole analysis for MEG neuroimaging data.
    Jun SC; George JS; Paré-Blagoev J; Plis SM; Ranken DM; Schmidt DM; Wood CC
    Neuroimage; 2005 Oct; 28(1):84-98. PubMed ID: 16023866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data.
    Kpekpena C; Muthukumarana S
    Comput Math Methods Med; 2018; 2018():8134132. PubMed ID: 30159005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical Bayesian spatiotemporal analysis of revascularization odds using smoothing splines.
    Silva GL; Dean CB; Niyonsenga T; Vanasse A
    Stat Med; 2008 Jun; 27(13):2381-401. PubMed ID: 17944001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian analysis of proportional hazards models built from monotone functions.
    Gelfand AE; Mallick BK
    Biometrics; 1995 Sep; 51(3):843-52. PubMed ID: 7548703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian partitioning for mapping disease risk using a matched case-control approach to confounding.
    Costain DA
    Biostatistics; 2013 Jan; 14(1):99-112. PubMed ID: 22952389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian approach to DNA sequence segmentation.
    Boys RJ; Henderson DA
    Biometrics; 2004 Sep; 60(3):573-81; discussion 581-8. PubMed ID: 15339274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large hierarchical Bayesian analysis of multivariate survival data.
    Gustafson P
    Biometrics; 1997 Mar; 53(1):230-42. PubMed ID: 9147593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian Latent Class Analysis Tutorial.
    Li Y; Lord-Bessen J; Shiyko M; Loeb R
    Multivariate Behav Res; 2018; 53(3):430-451. PubMed ID: 29424559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.
    Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.